4 research outputs found
Additional file 2: Table S2. of Does the reason for discontinuation of a first TNF inhibitor influence the effectiveness of a second TNF inhibitor in axial spondyloarthritis? Results from the Swiss Clinical Quality Management Cohort
ASDAS-CRP response rates after 1 year of treatment with a second TNFi, stratified by the reason for discontinuation of the first TNF inhibitor. (DOC 38 kb
Additional file 3: Table S1. of Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
Impact of obesity and overweight status on different outcomes after 1 year of treatment with a first TNFi in unadjusted analyses. (DOC 34 kb
Additional file 4: Table S2. of Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
Crude response rates at 1 year of treatment with a first TNFi after stratification for different BMI categories for the population with complete covariate data in multivariable analyses. (DOC 37 kb
Additional file 2: Figure S2. of Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
Body height before and after correction for kyphosis by using the occiput-to-wall distance. (DOC 118 kb